Show simple item record

Systemic conditioned medium treatment from interleukin-1 primed mesenchymal stem cells promotes recovery after stroke

dc.contributor.authorCunningham, Catriona J
dc.contributor.authorWong, Raymond
dc.contributor.authorBarrington, Jack
dc.contributor.authorTamburrano, Sabrina
dc.contributor.authorPinteaux, Emmanuel
dc.contributor.authorAllan, Stuart M.
dc.date.accessioned2020-04-28T16:25:00Z
dc.date.available2020-04-28T16:25:00Z
dc.date.issued2020-01-21
dc.identifier.citationCunningham , C J , Wong , R , Barrington , J , Tamburrano , S , Pinteaux , E & Allan , S M 2020 , ' Systemic conditioned medium treatment from interleukin-1 primed mesenchymal stem cells promotes recovery after stroke ' , Stem cell research & therapy , vol. 11 , 32 . https://doi.org/10.1186/s13287-020-1560-yen
dc.identifier.issn1757-6512
dc.identifier.otherPURE: 161956167
dc.identifier.otherPURE UUID: 2eb42bf0-aacb-48ac-9c55-a45ca9cc9727
dc.identifier.otherORCID: /0000-0002-9216-9414/work/67687385
dc.identifier.otherScopus: 85078239291
dc.identifier.otherWOS: 000521379800005
dc.identifier.urihttps://hdl.handle.net/2164/14194
dc.descriptionThis work was supported by the Engineering and Physical Sciences Research Council (EPSRC, UK) and Medical Research Council (MRC, UK) Centre for Doctoral Training in Regenerative Medicine studentship grant EP/L014904/1 and the Stroke Association (TSA 2017/03).en
dc.language.isoeng
dc.relation.ispartofStem cell research & therapyen
dc.rights© The Author(s). 2020 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.en
dc.subjectcell therapyen
dc.subjectconditioned mediumen
dc.subjectmesenchymal stem cellen
dc.subjectsecretomeen
dc.subjectstrokeen
dc.subjectMesenchymal stem cellen
dc.subjectStrokeen
dc.subjectCell therapyen
dc.subjectConditioned mediumen
dc.subjectSecretomeen
dc.subjectFUNCTIONAL RECOVERYen
dc.subjectBEHAVIORen
dc.subjectMODELen
dc.subjectNEUROPROTECTIONen
dc.subjectTRANSPLANTATIONen
dc.subjectINFLAMMATIONen
dc.subjectTHERAPEUTIC BENEFITen
dc.subjectCEREBRAL-ISCHEMIAen
dc.subjectBRAINen
dc.subjectMARROW STROMAL CELLSen
dc.subjectR Medicineen
dc.subjectMolecular Medicineen
dc.subjectBiochemistry, Genetics and Molecular Biology (miscellaneous)en
dc.subjectMedicine (miscellaneous)en
dc.subjectCell Biologyen
dc.subjectEngineering and Physical Sciences Research Council (EPSRC)en
dc.subjectEP/L014904/1en
dc.subject.lccRen
dc.titleSystemic conditioned medium treatment from interleukin-1 primed mesenchymal stem cells promotes recovery after strokeen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Medical Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Institute of Medical Sciencesen
dc.description.statusPeer revieweden
dc.description.versionPublisher PDFen
dc.identifier.doihttps://doi.org/10.1186/s13287-020-1560-y
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85078239291&partnerID=8YFLogxKen
dc.identifier.vol11en


Files in this item

Thumbnail
Name:
Cunningham_etal_SCRT_Systemic_ ...
Size:
1.632Mb
Format:
PDF
View/Open

This item appears in the following Collection(s)

Show simple item record